No Data
Lotus Holding (600186.SH): Cumulatively repurchased 0.39% of shares.
Gelonghui, December 2丨Lianhua Holdings (600186.SH) announced that in November 2024, the company had repurchased a total of 6,920,000 shares through centralized bidding trades, accounting for 0.39% of the company's total share capital. The highest transaction price was 5.00 yuan per share, and the lowest transaction price was 4.72 yuan per share, with a total payment amount of 33,795,413.63 yuan (excluding transaction costs). As of November 30, 2024, the company had cumulatively repurchased 6,920,000 shares through centralized bidding trades, accounting for 0.39% of the company's current total share capital.
Lotus Health Group (SHSE:600186) Might Have The Makings Of A Multi-Bagger
Lotus Holding (600186.SH): Intends to appoint Qian Cheng as the company's Chief Compliance Officer.
Gelonghui on November 22nd: Lianhua Holdings (600186.SH) announced that, in accordance with relevant provisions of the Company Law and other laws and regulations, as well as the Company's Articles of Association, Mr. Qian Cheng is nominated by the CEO to be the Chief Compliance Officer of the company. The term of office will be from the date of this meeting until the expiration of the ninth session of the board of directors.
Lotus Holding (600186.SH): First-time repurchase of 1.6 million shares
On November 18, Geelong announced that Lianhua Holdings (600186.SH) disclosed that on November 18, 2024, the company repurchased 1,600,000 shares of the company for the first time through the Shanghai Stock Exchange trading system in a centralized auction trading method, accounting for 0.09% of the total equity of the company. The highest transaction price was 4.93 yuan/share, the lowest transaction price was 4.88 yuan/share, and the total amount paid was RMB 7,852,000 yuan (excluding transaction costs).
Lotus Holding (600186.SH): Granted 1.9815 million stock options and 1.321 million restricted stocks to the incentive objects.
GeLongHui, November 7th | Lianhua Holdings (600186.SH) announced that the company has agreed to set November 7, 2024 as the grant date of this incentive plan, granting 1.9815 million stock options and 1.321 million restricted stocks to 14 eligible incentive recipients, with an exercise price of 3.24 yuan per share and a grant price of 1.62 yuan per share.
Retail Investors Among Lotus Health Group Company's (SHSE:600186) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 5.4% Last Week
Risks Still Elevated At These Prices As Lotus Health Group Company (SHSE:600186) Shares Dive 32%
